Platinum‐combination chemotherapy with or without immune‐checkpoint inhibitor in patients with postoperative recurrent non‐small cell lung cancer previously treated with adjuvant platinum‐doublet chemotherapy: A multicenter retrospective study

BACKGROUND: Rechallenge with platinum‐combination chemotherapy in patients with advanced non‐small cell lung cancer (NSCLC) after disease progression on platinum‐combination chemotherapy occasionally leads to a favorable response. The efficacy and safety of platinum‐combination chemotherapy with or...

Descripción completa

Detalles Bibliográficos
Autores principales: Hisakane, Kakeru, Tozuka, Takehiro, Takahashi, Satoshi, Taniuchi, Namiko, Nishijima, Nobuhiko, Atsumi, Kenichiro, Okano, Tetsuya, Seike, Masahiro, Hirose, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363783/
https://www.ncbi.nlm.nih.gov/pubmed/37290434
http://dx.doi.org/10.1111/1759-7714.14992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363783/
https://www.ncbi.nlm.nih.gov/pubmed/37290434
http://dx.doi.org/10.1111/1759-7714.14992

Ejemplares similares